(Q46032035)

18 December 2017

title

Minimal hepatic encephalopathy is associated with falls. (English)

1 reference

18 December 2017

main subject

hepatic encephalopathy

1 reference

7

1 reference

18 December 2017

German Soriano

8

1 reference

18 December 2017

author name string

Eva Román

1

1 reference

18 December 2017

Joan Córdoba

2

1 reference

18 December 2017

Maria Torrens

3

1 reference

18 December 2017

Xavier Torras

4

1 reference

18 December 2017

Càndid Villanueva

5

1 reference

18 December 2017

Víctor Vargas

6

1 reference

18 December 2017

language of work or name

English

0 references

publication date

26 October 2010

1 reference

18 December 2017

The American Journal of Gastroenterology

published in

1 reference

18 December 2017

volume

106

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

476-482

1 reference

18 December 2017

Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Minimal hepatic encephalopathy matters in daily life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Critical flicker frequency for quantification of low-grade hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Inhibitory control test for the diagnosis of minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Neuropsychological characterization of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Quality of life in cirrhosis is related to potentially treatable factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Screening of subclinical hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Minimal hepatic encephalopathy impairs fitness to drive

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Bone disorders in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Operative risk of total hip and knee arthroplasty in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Osteoporosis and skeletal fractures in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Normality tables in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Falls, depression and antidepressants in later life: a large primary care appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Patterns and predictors of inpatient falls and fall-related injuries in a large academic hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Multifactorial assessment and targeted intervention for preventing falls and injuries among older people in community and emergency care settings: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Prognostic validity of the Timed Up-and-Go test, a modified Get-Up-and-Go test, staff's global judgement and fall history in evaluating fall risk in residential care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Prevention of falls in the elderly trial (PROFET): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Fall risk: the clinical relevance of falls and how to integrate fall risk with fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Fracture risks of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Effect of selective serotonin reuptake inhibitors on the risk of fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Increased brain serotonin turnover correlates with the degree of shunting and hyperammonemia in rats following variable portal vein stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Rifaximin treatment in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

The patient who falls: "It's always a trade-off".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

Persistence of cognitive impairment after resolution of overt hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.413

21 January 2018

Identifiers

DOI

10.1038/AJG.2010.413

1 reference

18 December 2017

1 reference

18 December 2017